antitumor agent (Clarion)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameantitumor agent (Clarion)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhospholipase C inhibitorsProtein kinase C inhibitors
TargetsPhospholipase CProtein kinase C
Therapy Area/IndicationsColonic NeoplasmsBreast NeoplasmsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesClarion Pharmaceutical Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesClarion Pharmaceutical Co
Active IndicationsN/A
Inactive IndicationsColonic NeoplasmsBreast NeoplasmsLeukemia

Other Information

ATC CodeN/A
Related LinksN/A